Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation
-
Bejanyan, Nelli (University of Minnesota)
;
Zhang, Mei-Jie (Medical College of Wisconsin) ;
Wang, Hai-Lin (Medical College of Wisconsin) ;
Lazaryan, Aleksandr (University of Minnesota) ;
de Lima, Marcos (University Hospitals Case Medical Center) ;
Marks, David I. (University Hospitals Bristol NHS Trust) ;
Sandmaier, Brenda M. (Fred Hutchinson Cancer Research Center) ;
Bachanova, Veronika (University of Minnesota) ;
Rowe, Jacob (Shaare Zedek Medical Center) ;
Tallman, Martin (Memorial Sloan Kettering Cancer Center) ;
Kebriaei, Partow (The University of Texas MD Anderson Cancer Center) ;
Kharfan-Dabaja, Mohamed (H. Lee Moffitt Cancer Center and Research Institute) ;
Peter Gale, Robert (Imperial College London) ;
Lazarus, Hillard M. (University Hospitals Cleveland Medical Center) ;
Ustun, Celalettin (University of Minnesota) ;
Copelan, Edward (Carolinas HealthCare System) ;
Ky Hamilton, Betty (Cleveland Clinic Taussig Cancer Institute) ;
Schiller, Gary (David Geffen School of Medicine at UCLA) ;
Hogan, Willian (Mayo Clinic Rochester) ;
Hashmi, Shahrukh (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ;
Seftel, Matthew (CancerCare Manitoba) ;
Kanakry, Christopher G. (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ;
Olsson, Richard F. (Uppsala University) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Saber, Wael (Medical College of Wisconsin) ;
Khoury, H.Jean (Emory University Hospital) ;
Weisdorf, Daniel J. (University of Minnesota) ;
Universitat Autònoma de Barcelona
guest ::
Subscribe to this discussion. You will then receive all new comments by email.
